Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

5 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Pheochromocytoma and Paraganglioma PDQ®

Topic overview

Comprehensive clinical reference from NCI covering diagnosis, staging, and treatment approaches for childhood pheochromocytoma and paraganglioma. Provides evidence-based guidance for managing these rare catecholamine-secreting neuroendocrine tumors in pediatric patients.

Key Takeaways

  • Pheochromocytomas arise from adrenal medulla; paragangliomas from extra-adrenal chromaffin tissue—both secrete catecholamines.
  • Pediatric cases often present with sustained hypertension, headache, sweating, and palpitations due to excess catecholamine release.
  • Genetic syndromes (MEN2, VHL, NF1, SDH mutations) account for majority of pediatric cases—family history and genetic testing crucial.
  • Preoperative alpha-blockade essential to prevent hypertensive crisis during surgical resection, the primary curative treatment.
  • Malignant potential exists; long-term surveillance required for metastatic disease and recurrence, especially in syndromic cases.

Keywords

Hashtags

Full guideline text

Full text not available for this guideline
How to cite: GlobalCastMD. Pheochromocytoma and Paraganglioma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2388

Comments

Loading comments...